Sproule Rizwana F

VP Regulatory Affairs at Kite Pharma, Inc.

Sold, on record
$6.2M
Dollars the filings state
Form 4 sales
11
Latest Mar 15, 2016
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Kite Pharma, Inc.Unusual
    Aug 17 2015

    Sold 9,567 shares at $60.88 ($582k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 84.9% of holdings ($686k position)1,695 shares left1x usual sizeFiling

  2. 2 Form 4 sale Kite Pharma, Inc.Unusual
    Sep 15 +29 days

    Sold 9,567 shares at $64.36 ($616k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 76.5% of holdings ($805k position)2,941 shares left1x usual sizeFiling

  3. 3 Form 4 sale Kite Pharma, Inc.Unusual
    Oct 15 +30 days

    Sold 9,567 shares at $62.58 ($599k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 76.5% of holdings ($783k position)2,941 shares left1x usual sizeFiling

  4. 4 Form 4 sale Kite Pharma, Inc.Unusual
    Nov 16 +32 days

    Sold 9,567 shares at $78.13 ($748k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 76.5% of holdings ($977k position)2,941 shares left1x usual sizeFiling

  5. 5 Form 4 sale Kite Pharma, Inc.Unusual
    Dec 15 +29 days

    Sold 9,567 shares at $63.76 ($610k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 76.5% of holdings ($798k position)2,941 shares left1x usual sizeFiling

  6. 6 Form 4 sale Kite Pharma, Inc.Unusual
    Jan 19 +35 days

    Sold 9,567 shares at $55.49 ($531k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 52.3% of holdings ($1M position)8,741 shares left1x usual sizeFiling

  7. 7 Form 4 sale Kite Pharma, Inc.Unusual
    Feb 17 +29 days

    Sold 9,567 shares at $45.08 ($431k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 52.3% of holdings ($825k position)8,741 shares left1x usual sizeFiling

  8. 8 Form 4 sale Kite Pharma, Inc.Unusual
    Mar 15 +27 days

    Sold 8,500 shares at $45.27 ($385k)

    Sproule Rizwana F, VP Regulatory Affairs

    Sold 45.4% of holdings ($847k position)10,211 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Sproule Rizwana F
Source
Mar 15, 2016Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale8,500$385k45.4%UnusualSEC
Feb 17, 2016Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$431k52.3%UnusualSEC
Jan 19, 2016Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$531k52.3%UnusualSEC
Dec 15, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$610k76.5%UnusualSEC
Nov 16, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$748k76.5%UnusualSEC
Oct 15, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$599k76.5%UnusualSEC
Sep 15, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$616k76.5%UnusualSEC
Aug 17, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$582k84.9%UnusualSEC
Jul 15, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$688k84.9%UnusualSEC
Jun 15, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$545k84.9%UnusualSEC
May 15, 2015Kite Pharma, Inc.VP Regulatory AffairsForm 4 sale9,567$480k84.9%UnusualSEC